Target intelligence / Profile preview

Glycosaminoglycan Biosynthesis (None)

Target
None
Molecular classification
Enzyme
01

Overview

Glycosaminoglycan (GAG) biosynthesis is the cellular process of assembling GAGs, linear polysaccharides, and attaching them to core proteins to form proteoglycans. GAGs are essential components of the extracellular matrix and cell surfaces, crucial for cell signaling, structural integrity, and tissue hydration. The biosynthesis involves activated sugar donors, formation of a tetrasaccharide linker, polymerization, and modification reactions such as sulfation and epimerization. Key enzymes include xylosyltransferases (XYLT1/2), galactosyltransferases (B4GALT7, B3GALT6), glucuronosyltransferase (GLCAT1), EXTL3, CSGALNACT1/2, exostosins (EXT1/2), and NDST enzymes. Defects in these enzymes can lead to connective tissue disorders.

02

Mechanism of action

Inhibition of enzymes involved in GAG synthesis, modification of GAG structure

03

Biological functions

Extracellular matrix organizationCell signalingTissue hydrationCell-cell interactionsGrowth factor regulationWound healing
04

Disease associations

Connective tissue disorders
05

Safety considerations

Off-target effects due to broad expression of GAGsPotential for immune reactions to modified GAGs

Beyond the preview

Go deeper on Glycosaminoglycan Biosynthesis (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosaminoglycan Biosynthesis (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call